NDC 51808-209

Thyrotropin Releasing Hormone TRH

Thyrotropin Releasing Hormone

Thyrotropin Releasing Hormone TRH is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Protirelin.

Product ID51808-209_ad867c7e-d1fa-4587-9c3e-26a40fcf0ccc
NDC51808-209
Product TypeHuman Prescription Drug
Proprietary NameThyrotropin Releasing Hormone TRH
Generic NameThyrotropin Releasing Hormone
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-06-19
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NamePROTIRELIN
Active Ingredient Strength500 ug/mL
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-209-01

1 mL in 1 VIAL (51808-209-01)
Marketing Start Date2012-06-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-209-01 [51808020901]

Thyrotropin Releasing Hormone TRH SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-19
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
PROTIRELIN500 ug/mL

OpenFDA Data

SPL SET ID:af5da799-76bf-415a-9dc7-99c7ddc62bc4
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.